<DOC>
	<DOCNO>NCT00747747</DOCNO>
	<brief_summary>The goal study demonstrate SINUclean DM® spray , add standard ( amoxicillin/clavulanate ) therapy acute episode sinusitis ( acute , subacute chronic ) , safe ad capable determine resolution symptom short time comparison standard therapy without co-adjuvant , simple saline lavage .</brief_summary>
	<brief_title>Sinuclean 's Treatment Of Sinusitis ' Symptoms</brief_title>
	<detailed_description>The randomized subject diagnosis acute episode sinusitis symptom mucus paranasal sinus , treat his/her condition background amoxicillin/clavulanate inhalation Sinuclean Saline , control group use spray symptom relief . Anti-histaminic , steroidal anti-inflammatory drug forbidden . The patient request evaluate state symptom record diary - pain feeling facial oppression ; - nasal drip anterior posterior ; - nasal congestion . SCALE 0 = symptom 1 . = mild symptom : clearly perceptible , easily tolerate 2 . = moderate symptom : clear awareness symptom , annoy tolerable 3 . = severe : symptom annoying , difficult tolerate , interfere ordinary life Four measure per day ( 2 administration therapy - before/after ) median use ; plus evening measure `` retrospective '' past 12 hour . If possible assessed status paranasal sinuses treatment CT scan . The treatment interval week . After baseline start treatment , plan two control visit . The subject complete study first control visit without symptom . After second visit , symptom still present , subject complete `` treatment-failure '' .</detailed_description>
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Male female sex . Age &gt; 18 year old . Diagnosis acute episode sinusitis ( acute , subacute chronic background ) , confirm CT scan image . Presence mucus paranasal sinus . Symptoms facial pain associate congestion mucosa paranasal sinuses least three day . Written informed consent . Expressed intention compliance study requirement . In case female subject : ongoing pregnancy lactating ; condition fecundity without abstinence . Assumption , study , drug interfere evaluation investigational drug ( see Section `` Concomitant Therapy '' ) Possible necessity treatment , study , drug allow ( see section `` Concomitant Therapy '' ) . Clinical condition ( systemic pathology ) interfere assessment safety efficacy investigational drug , example : viral allergic rhinitis active secretive symptomatology , presence visible nasal polyp , diagnosis immobile cilium syndrome , diseases determine immunodeficiency cystic fibrosis immunocompromission renal insufficiency , dialysis , pathology apparatus , opinion investigator , necessity supplementary antibiotic therapy , due pathology , besides one standard sinusitis . Psychical condition compatible participation clinical trial . Alcohol abuse dependency stupefacents Smoking period study History intolerance allergy component SINUclean DM® Surgical medical intervention jeopardize complete performance trial , 4 wks precede administration inform consent Planning surgical medical intervention jeopardize completion trial Participation clinical trial , ongoing terminate since less 30 day begin present experiment . Preceding randomization trial . Be component investigator ' staff relative member staff .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Sinusitis</keyword>
</DOC>